Takeshi Matsumoto1,2, Takuya Shiotani2, Kazuko Ino2, Kana Miyazaki2, Atsushi Fujieda2, Yuka Sugimoto2, Isao Tawara2, Motoko Yamaguchi2, Kohshi Ohishi1,2, Masahiro Masuya2, Hideo Wada3, Naoyuki Katayama2 (1.Transfusion and Cell Therapy, Mie University Hospital, Tsu, Japan, 2.Hematology and Oncology, School of Medicine, Mie University, Tsu, Japan, 3.Dept. Laboratory Medicine, School of Medicine, Mie University, Tsu, Japan)
Session information
Poster Session
Sat. Oct, 13
Poster Session 2-31 Thromabosis
Sat. Oct 13, 2018 5:10 PM - 5:50 PM Poster2 (Osaka International Convention Center, 5F Main Foyer)
Chair: Hideo Wada (Department of Molecular and Laboratory Medicine, Mie University Graduate School of Medicine)
[PS2-31-2] Eculizumab therapy for a patient with the senile-onset atypical hemolytic uremic syndrome
Naoko Yuasa, Motoharu Shibusawa, Naoki Matsuyama, Jiro Tadokoro, Makoto Kashimura (Shinmatsudo Central General Hospital, Department of Hematology., Chiba-ken, Japan)
[PS2-31-3] Eculizumab is effective for Budd-Chiari syndrome with paroxysmal nocturnal hemoglobinuria
Kentaro Yoshinaga1, Masayuki Shiseki1, Midori Ishiyama1, Akihito Shinohara1, Hiroshi Kazama1, Shotaro Hagiwara1, Naoki Mori1, Tomomi Kogiso2, Shuji Sakai3, Katsutoshi Tokushige2, Junji Tanaka1 (1.Dept Hematol., Tokyo Women's Univ. Tokyo, Japan, 2.Institute of Gastroenterology, Dept. internal medicine, Tokyo Women's Medical Univ., 3.Dept. Diagnostic Imaging and Nuclear Medicine, Tokyo Women's Medical Univ.)
Toshiki Natazuka (Shinseikai Toyama Hospital)
Imado Takehito1, Norimitsu Tanaka1, Ako Mori1, Yoshifumi Shimizu1, Takahiro Okamoto2, Masateru Kato3, Junya Yamazaki4, Akihiro Sawada5, Tazuko Tokugawa5, Satoshi Higasa5 (1.Hematology, Takarazuka City Hospital, hyogo, Japan, 2.Naniwa Roland, Hyogo, Japan, 3.Clinical Laboratory, Takarazuka City Hospital, Takarazuka, 4.Surgery, Takarazuka City Hospital, Hyogo, Japan, 5.Hematology, Hyogo College of Medicine)
Akira Katsumi1, Seara Ikeno1, Hiroshi Watanabe2, Tadashi Matsushita3, Tetsuhito Kojima4 (1.Department of Hematology, National Center for Geriatrics and Gerontology, 2.Department of Clinical Research-Development, National Center for Geriatrics and Gerontology, 3.Department of Transfusion, Nagoya University Hospital, 4.Department of Medical Technology, Nagoya University)
Akihito Fujimi1, Yasuhiro Nagamachi1, Naofumi Yamauchi1, Fumito Tamura2, Tomohiro Kimura2, Naoya Miyajima2, Hidetoshi Inomata2, Eri Nozawa2, Kazuhiko Koike2, Yoshiro Gotoh2, Kohji Ihara2, Takuji Nishisato2, Junji Kato3 (1.Department of Hematology, Sapporo Kiyota Hospital, Sapporo, Japan, 2.Department of Internal Medicine, Sapporo Kiyota Hospital, Sapporo, Japan, 3.Department of Medical Oncology, Sapporo Medical University, Sapporo, Japan)